Cargando…

SARS-CoV-2 infection long time after full vaccination is related to a lack of neutralizing antibodies

SARS-CoV-2 infections after COVID-19 vaccination are not unexpected, but those occurring more than 14 days after second vaccine dose need to be investigated. We describe a well-characterized infection which occurred almost 2 months after full vaccination, and provide the evidence of a link with a la...

Descripción completa

Detalles Bibliográficos
Autores principales:	Alidjinou, Enagnon Kazali, Gaillot, Olivier, Guigon, Aurélie, Tinez, Claire, Lazrek, Mouna, Bocket, Laurence, Engelmann, Ilka, Hober, Didier
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Elsevier Inc. 2022
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8487095/ https://www.ncbi.nlm.nih.gov/pubmed/34731684 http://dx.doi.org/10.1016/j.diagmicrobio.2021.115565

Ejemplares similares

Emergence of Q493R mutation in SARS-CoV-2 spike protein during bamlanivimab/etesevimab treatment and resistance to viral clearance
por: Guigon, Aurélie, et al.
Publicado: (2022)

Rapid syndromic testing for respiratory viral infections in children attending the emergency department during COVID-19 pandemic in Lille, France, 2021–2022
por: Ouafi, Mahdi, et al.
Publicado: (2022)

Necessity to critically review the automatic results of the Xpert Flu assay
por: Engelmann, Ilka, et al.
Publicado: (2017)

Respiratory virus detection in returning travelers and pilgrims from the Middle East
por: Mercier, Ambroise, et al.
Publicado: (2023)

Enteroviruses and Type 1 Diabetes Mellitus: An Overlooked Relationship in Some Regions
por: Alhazmi, Abdulaziz, et al.
Publicado: (2020)

Secondary syphilis in a 14-month-old girl and child-to-mother transmission
por: Regueme, Alexandre, et al.
Publicado: (2023)

Four complete genomes of human parvovirus B19 from amniotic fluid specimens
por: Alidjinou, Enagnon Kazali, et al.
Publicado: (2023)

Sensitivity of SARS-CoV-2 variant Delta to serum neutralization in BNT162b2 vaccinees and unvaccinated COVID-19 recovered cases
por: Alidjinou, Enagnon Kazali, et al.
Publicado: (2021)

Emergence of Fluoxetine-Resistant Variants during Treatment of Human Pancreatic Cell Cultures Persistently Infected with Coxsackievirus B4
por: Alidjinou, Enagnon Kazali, et al.
Publicado: (2019)

Evaluation of a rapid semiquantitative lateral flow assay for the prediction of serum neutralizing activity against SARS-CoV-2 variants
por: Hirabidian, Mickael, et al.
Publicado: (2022)

Persistent coxsackievirus B infection and pathogenesis of type 1 diabetes mellitus
por: Nekoua, Magloire Pandoua, et al.
Publicado: (2022)

Fluoxetine Can Inhibit SARS-CoV-2 In Vitro
por: Dechaumes, Arthur, et al.
Publicado: (2021)

Spatial and Temporal Virus Load Dynamics of SARS-CoV-2: A Single-Center Cohort Study
por: Alidjinou, Enagnon Kazali, et al.
Publicado: (2021)

Prospective Evaluation of a Commercial Dengue NS1 Antigen Rapid Diagnostic Test in New Caledonia
por: Alidjinou, Enagnon Kazali, et al.
Publicado: (2022)

Persistence of Coxsackievirus B4 in Pancreatic β Cells Disturbs Insulin Maturation, Pattern of Cellular Proteins, and DNA Methylation
por: Nekoua, Magloire Pandoua, et al.
Publicado: (2021)

Coxsackievirus B4 Can Infect Human Peripheral Blood-Derived Macrophages
por: Alidjinou, Enagnon Kazali, et al.
Publicado: (2015)

History of COVID-19 Symptoms and Seroprevalence of SARS-CoV-2 Antibodies in HIV-Infected Patients in Northern France after the First Wave of the Pandemic
por: Meybeck, Agnès, et al.
Publicado: (2021)

Effect of Coxsackievirus B4 Infection on the Thymus: Elucidating Its Role in the Pathogenesis of Type 1 Diabetes
por: Alhazmi, Abdulaziz, et al.
Publicado: (2021)

Fighting Enteroviral Infections to Prevent Type 1 Diabetes
por: Nekoua, Magloire Pandoua, et al.
Publicado: (2022)

Enteroviruses and Type 1 Diabetes: Candidate Genes Linked With Innate Immune Response
por: Alidjinou, Enagnon K., et al.
Publicado: (2015)

Enteroviral Pathogenesis of Type 1 Diabetes: The Role of Natural Killer Cells
por: Nekoua, Magloire Pandoua, et al.
Publicado: (2020)

Preanalytical Issues and Cycle Threshold Values in SARS-CoV-2 Real-Time RT-PCR Testing: Should Test Results Include These?
por: Engelmann, Ilka, et al.
Publicado: (2021)

In Vivo Persistence of Human Rhinoviruses in Immunosuppressed Patients
por: Engelmann, Ilka, et al.
Publicado: (2017)

Low Serum Levels of Interferon Alpha in COVID-19 Patients Are Associated with Older Age
por: Alidjinou, Enagnon Kazali, et al.
Publicado: (2022)

Viruses and Endocrine Diseases
por: Nekoua, Magloire Pandoua, et al.
Publicado: (2023)

A comparison of high-throughput SARS-CoV-2 sequencing methods from nasopharyngeal samples
por: Gerber, Zuzana, et al.
Publicado: (2022)

Serum neutralization of SARS coronavirus 2 Omicron sublineages BA.1 and BA.2 and cellular immune responses 3 months after booster vaccination
por: Alidjinou, Enagnon Kazali, et al.
Publicado: (2023)

The role of the surface ligand on the performance of electrochemical SARS-CoV-2 antigen biosensors
por: Szunerits, Sabine, et al.
Publicado: (2021)

Immunogenicity of BNT162b2 vaccine booster against SARS-CoV-2 Delta and Omicron variants in nursing home residents: A prospective observational study in older adults aged from 68 to 98 years
por: Alidjinou, Enagnon Kazali, et al.
Publicado: (2022)

SARS-CoV-2 detection using a nanobody-functionalized voltammetric device
por: Pagneux, Quentin, et al.
Publicado: (2022)

Clofoctol inhibits SARS-CoV-2 replication and reduces lung pathology in mice
por: Belouzard, Sandrine, et al.
Publicado: (2022)

Impaired Functional T-Cell Response to SARS-CoV-2 After Two Doses of BNT162b2 mRNA Vaccine in Older People
por: Demaret, Julie, et al.
Publicado: (2021)

Neurophysiological findings and their prognostic value in critical COVID-19 patients: An observational study
por: Niguet, Jean-Paul, et al.
Publicado: (2021)

Genes Involved in miRNA Biogenesis Are Not Downregulated in SARS-CoV-2 Infection
por: Garnier, Nathalie, et al.
Publicado: (2023)

Cytomegalovirus in donors for fecal microbiota transplantation, the phantom menace?
por: Galpérine, Tatiana, et al.
Publicado: (2023)

Infections virales, COVID-19 et survenue de pathologies auto-immunes : le modèle du diabète de type 1
por: Nekoua, M.P., et al.
Publicado: (2021)

LACK OF IDENTITY IN NEUTRALIZING AND HEMAGGLUTINATION-INHIBITING ANTIBODIES AGAINST INFLUENZA VIRUSES
por: Walker, Duard L., et al.
Publicado: (1950)

Lack of protection in vivo with neutralizing monoclonal antibodies to transmissible gastroenteritis virus
por: Wesley, R.D., et al.
Publicado: (1988)

Lack of MERS Coronavirus Neutralizing Antibodies in Humans, Eastern Province, Saudi Arabia
por: Gierer, Stefanie, et al.
Publicado: (2013)

The promising efficacy of a risk-based letermovir use strategy in CMV-positive allogeneic hematopoietic cell recipients
por: Sourisseau, Mathilde, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_3afkp6rupf1d8nclirtka7r820